AbCellera Biologics Inc.
ABCL
$3.43
-$0.18-4.99%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
6/25/2025
-
MarketBeat
6/24/2025
-
MarketBeat
6/20/2025
-
MarketBeat
6/18/2025
-
MarketBeat
6/16/2025
-
Ticker Report
6/13/2025
-
TipRanks Financial Blog
6/13/2025
-
SeekingAlpha
6/13/2025
-
MarketBeat
6/13/2025
-
Ticker Report
6/12/2025
-
Ticker Report
6/11/2025
-
MarketBeat
6/11/2025
-
Ticker Report
6/11/2025
-
MarketBeat
6/11/2025
-
GuruFocus
6/10/2025
-
MarketBeat
6/9/2025
-
Yahoo! Finance: News
6/4/2025
-
MarketBeat
6/3/2025
-
Zacks Investment Research
6/3/2025
-
Simply Wall St
6/2/2025
-
Fool.com Headlines
5/31/2025
-
Insider Monkey
5/31/2025
-
MarketBeat
5/30/2025
-
TipRanks Financial Blog
5/30/2025
-
Business Wire
5/26/2025
-
MarketBeat
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, May 8, 2025
Period Date
Monday, March 31, 2025
Next Filing
Week of Aug 4 and 8 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
604 559 9005
Address
150 West 4th Ave
Vancouver, BC V5Y 1G6
Vancouver, BC V5Y 1G6
Country
Year Founded
Business Description
Sector
AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its product pipeline includes ABCL635, an...
more